| NDC Code: |
51144-050 |
| Proprietary Name: |
ADCETRIS |
| Suffix: |
|
| Non-Proprietary Name: |
brentuximab vedotin |
| Dosage Form: |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
25-08-2011 |
| Category Name: |
BLA |
| Application Number: |
BLA125388 |
| Labeler: |
SEATTLE GENETICS, INC. |
| Substance Name: |
BRENTUXIMAB VEDOTIN |
| Active Numerator Strength: |
50 |
| Active Ingredient Unit: |
mg/10.5mL |
| Pharm Classes: |
CD30-directed Antibody Interactions [MoA],CD30-directed Immunoconjugate [EPC],Immunoconjugates [Chemical/Ingredient],Microtubule Inhibition [PE] |
| DEA Schedule: |
|
